US Stock MarketDetailed Quotes

PMVP PMV Pharmaceuticals

Watchlist
  • 0.997
  • -0.003-0.34%
Close May 2 16:00 ET
  • 0.997
  • 0.0000.00%
Post 16:00 ET
51.78MMarket Cap-0.87P/E (TTM)

PMV Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
6.63%85.45M
33.15%25.17M
11.51%21.89M
0.24%20.17M
-15.17%18.22M
4.01%80.13M
-10.68%18.9M
1.31%19.63M
12.51%20.12M
15.37%21.48M
Selling and administrative expenses
11.03%26.92M
106.54%11.4M
-18.22%4.94M
-11.74%5.54M
-21.41%5.04M
-3.21%24.25M
-10.05%5.52M
5.83%6.04M
-2.24%6.28M
-5.54%6.41M
-General and administrative expense
11.03%26.92M
106.54%11.4M
-18.22%4.94M
-11.74%5.54M
-21.41%5.04M
-3.21%24.25M
-10.05%5.52M
5.83%6.04M
-2.24%6.28M
-5.54%6.41M
Research and development costs
4.73%58.53M
2.88%13.77M
24.74%16.95M
5.67%14.63M
-12.52%13.19M
7.50%55.89M
-10.94%13.38M
-0.59%13.59M
20.77%13.84M
27.35%15.07M
Operating profit
-6.63%-85.45M
-33.15%-25.17M
-11.51%-21.89M
-0.24%-20.17M
15.17%-18.22M
-4.01%-80.13M
10.68%-18.9M
-1.31%-19.63M
-12.51%-20.12M
-15.37%-21.48M
Net non-operating interest income expense
-4.62%10.66M
-27.76%2.29M
-12.37%2.62M
3.89%2.8M
26.97%2.95M
208.00%11.17M
76.18%3.17M
165.48%2.98M
346.36%2.7M
915.28%2.33M
Non-operating interest income
-4.62%10.66M
-27.76%2.29M
-12.37%2.62M
3.89%2.8M
26.97%2.95M
208.00%11.17M
76.18%3.17M
165.48%2.98M
346.36%2.7M
915.28%2.33M
Other net income (expense)
-633.33%-16K
-466.67%-119K
2,925.00%121K
-183.33%-17K
-103.70%-1K
-96.55%3K
-205.00%-21K
-69.23%4K
80.65%-6K
165.85%27K
Other non- operating income (expenses)
-633.33%-16K
-466.67%-119K
2,925.00%121K
-183.33%-17K
-103.70%-1K
-96.55%3K
-205.00%-21K
-69.23%4K
80.65%-6K
165.85%27K
Income before tax
-8.48%-74.81M
-45.97%-23M
-15.10%-19.15M
0.26%-17.39M
20.17%-15.27M
5.96%-68.96M
18.55%-15.76M
8.76%-16.64M
-0.69%-17.43M
-3.78%-19.13M
Income tax
-805,100.00%-16.1M
0
74K
-404,425.00%-16.17M
0
122.22%2K
-1K
0
300.00%4K
0
Net income
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
Net income continuous Operations
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
Minority interest income
Net income attributable to the parent company
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.87%-58.71M
-45.98%-23M
-15.54%-19.23M
93.04%-1.21M
20.17%-15.27M
5.94%-68.96M
18.55%-15.76M
8.72%-16.64M
-0.73%-17.44M
-3.77%-19.13M
Basic earnings per share
20.83%-1.14
-45.16%-0.45
-8.82%-0.37
94.74%-0.02
28.57%-0.3
10.56%-1.44
27.91%-0.31
15.00%-0.34
0.00%-0.38
-2.44%-0.42
Diluted earnings per share
20.83%-1.14
-45.16%-0.45
-8.82%-0.37
94.74%-0.02
28.57%-0.3
10.56%-1.44
27.91%-0.31
15.00%-0.34
0.00%-0.38
-2.44%-0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 6.63%85.45M33.15%25.17M11.51%21.89M0.24%20.17M-15.17%18.22M4.01%80.13M-10.68%18.9M1.31%19.63M12.51%20.12M15.37%21.48M
Selling and administrative expenses 11.03%26.92M106.54%11.4M-18.22%4.94M-11.74%5.54M-21.41%5.04M-3.21%24.25M-10.05%5.52M5.83%6.04M-2.24%6.28M-5.54%6.41M
-General and administrative expense 11.03%26.92M106.54%11.4M-18.22%4.94M-11.74%5.54M-21.41%5.04M-3.21%24.25M-10.05%5.52M5.83%6.04M-2.24%6.28M-5.54%6.41M
Research and development costs 4.73%58.53M2.88%13.77M24.74%16.95M5.67%14.63M-12.52%13.19M7.50%55.89M-10.94%13.38M-0.59%13.59M20.77%13.84M27.35%15.07M
Operating profit -6.63%-85.45M-33.15%-25.17M-11.51%-21.89M-0.24%-20.17M15.17%-18.22M-4.01%-80.13M10.68%-18.9M-1.31%-19.63M-12.51%-20.12M-15.37%-21.48M
Net non-operating interest income expense -4.62%10.66M-27.76%2.29M-12.37%2.62M3.89%2.8M26.97%2.95M208.00%11.17M76.18%3.17M165.48%2.98M346.36%2.7M915.28%2.33M
Non-operating interest income -4.62%10.66M-27.76%2.29M-12.37%2.62M3.89%2.8M26.97%2.95M208.00%11.17M76.18%3.17M165.48%2.98M346.36%2.7M915.28%2.33M
Other net income (expense) -633.33%-16K-466.67%-119K2,925.00%121K-183.33%-17K-103.70%-1K-96.55%3K-205.00%-21K-69.23%4K80.65%-6K165.85%27K
Other non- operating income (expenses) -633.33%-16K-466.67%-119K2,925.00%121K-183.33%-17K-103.70%-1K-96.55%3K-205.00%-21K-69.23%4K80.65%-6K165.85%27K
Income before tax -8.48%-74.81M-45.97%-23M-15.10%-19.15M0.26%-17.39M20.17%-15.27M5.96%-68.96M18.55%-15.76M8.76%-16.64M-0.69%-17.43M-3.78%-19.13M
Income tax -805,100.00%-16.1M074K-404,425.00%-16.17M0122.22%2K-1K0300.00%4K0
Net income 14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M
Net income continuous Operations 14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M
Minority interest income
Net income attributable to the parent company 14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.87%-58.71M-45.98%-23M-15.54%-19.23M93.04%-1.21M20.17%-15.27M5.94%-68.96M18.55%-15.76M8.72%-16.64M-0.73%-17.44M-3.77%-19.13M
Basic earnings per share 20.83%-1.14-45.16%-0.45-8.82%-0.3794.74%-0.0228.57%-0.310.56%-1.4427.91%-0.3115.00%-0.340.00%-0.38-2.44%-0.42
Diluted earnings per share 20.83%-1.14-45.16%-0.45-8.82%-0.3794.74%-0.0228.57%-0.310.56%-1.4427.91%-0.3115.00%-0.340.00%-0.38-2.44%-0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More